Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

Tumor progression and metastasis.

Yokota J.

Carcinogenesis. 2000 Mar;21(3):497-503. Review.

2.

[Genetic and epigenetic alterations associated with cancer metastasis].

Tani M, Yokota J.

Gan To Kagaku Ryoho. 1999 Nov;26(13):2101-5. Review. Japanese.

PMID:
10584580
3.
4.

Metastasis-Associated genes and metastatic tumor progression.

Nicolson GL, Moustafa AS.

In Vivo. 1998 Nov-Dec;12(6):579-88. Review.

PMID:
9891220
5.

Toward an understanding of the molecular genetics of prostate cancer progression.

Lijovic M, Frauman AG.

J Environ Pathol Toxicol Oncol. 2003;22(1):1-15. Review.

PMID:
12678401
6.
7.

Molecular determinants of metastatic transformation.

Egan SE, Wright JA, Greenberg AH.

Environ Health Perspect. 1991 Jun;93:91-5. Review.

8.

Genetic regulation of metastatic progression.

Wright JA, Egan SE, Greenberg AH.

Anticancer Res. 1990 Sep-Oct;10(5A):1247-55. Review.

PMID:
2241100
9.

Quantitative variations in gene expression: possible role in cellular diversification and tumor progression.

Nicolson GL.

J Cell Biochem. 1991 Aug;46(4):277-83. Review. Erratum in: J Cell Biochem 1991 Oct;47(2):197.

PMID:
1757473
10.
11.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
12.

Molecular footprints of human lung cancer progression.

Yokota J, Kohno T.

Cancer Sci. 2004 Mar;95(3):197-204. Review.

13.

Metastasis suppressor genes: basic biology and potential clinical use.

Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M.

Clin Breast Cancer. 2003 Apr;4(1):51-62. Review.

PMID:
12744759
14.

Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.

Eastham JA, Grafton W, Martin CM, Williams BJ.

J Urol. 2000 Sep;164(3 Pt 1):814-9.

PMID:
10953161
15.

Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.

Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S.

BMC Cancer. 2008 Jul 1;8:187. doi: 10.1186/1471-2407-8-187.

16.

Oncogene transformation and the metastatic phenotype.

Chambers AF, Tuck AB.

Anticancer Res. 1988 Sep-Oct;8(5A):861-71. Review.

PMID:
3052258
17.

Cell cycle alterations and lung cancer.

Vincenzi B, Schiavon G, Silletta M, Santini D, Perrone G, Di Marino M, Angeletti S, Baldi A, Tonini G.

Histol Histopathol. 2006 Apr;21(4):423-35. Review.

PMID:
16437388
18.

Molecular mechanisms of metastasis.

Weber GF.

Cancer Lett. 2008 Nov 8;270(2):181-90. doi: 10.1016/j.canlet.2008.04.030. Epub 2008 Jun 5. Review.

PMID:
18522865
19.

Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.

Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW.

J Urol. 2003 Mar;169(3):1122-33. Review.

PMID:
12576866
20.

Genetic studies and molecular markers of bladder cancer.

Cordon-Cardo C, Sheinfeld J, Dalbagni G.

Semin Surg Oncol. 1997 Sep-Oct;13(5):319-27. Review.

PMID:
9259087
Items per page

Supplemental Content

Write to the Help Desk